| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$38 |
Proposed issue of securities - IMU
|
16 Jul 2025 10:39AM |
$0.425 |
$0.091 |
fallen by
78.59%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$38 |
Proposed issue of securities - IMU
|
16 Jul 2025 10:36AM |
$0.425 |
$0.091 |
fallen by
78.59%
|
|
| Imugene Limited (IMU) ORDINARY FULLY PAID |
Health Care |
$38 |
Imugene Completes $22.5M Placement and c.$15M SPP
|
16 Jul 2025 10:36AM |
$0.425 |
$0.091 |
fallen by
78.59%
|
|
IMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Imugene completed a $22.5M placement and approximately $15M via Share Purchase Plan (SPP).
- Proceeds will be used to advance clinical trials for Imugene’s immunotherapy candidates.
- The capital raising received strong support from both institutional and retail investors.
- Funds will support ongoing and future clinical programs, operational expansion, and general corporate activities.
- The announcement reiterates Imugene’s commitment to developing innovative immunotherapies for cancer.
- Details are provided on the allocation of shares, pricing, and the closing of the SPP.
- Recent board and operational updates are included, highlighting strategic priorities.
- The company expresses gratitude to shareholders for their continued support and participation.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$19 |
Proposed issue of securities - HIO
|
16 Jul 2025 10:31AM |
$0.021 |
$0.015 |
fallen by
28.57%
|
|
| Plato Income Maximiser Limited (PL8) ORDINARY FULLY PAID |
Financials |
$1,018 |
Net Tangible Asset Backing
|
16 Jul 2025 10:26AM |
$1.400 |
$1.360 |
fallen by
2.86%
|
|
| Ophir High Conviction Fund (OPH) ORDINARY UNITS FULLY PAID |
Financials |
$574 |
Update - Dividend/Distribution - OPH
|
16 Jul 2025 10:22AM |
$3.120 |
$2.580 |
fallen by
17.31%
|
|
| Beacon Minerals Limited (BCN) ORDINARY FULLY PAID |
Materials |
$296 |
Near Surface Laterite Mineralisation Identified at Iguana
|
16 Jul 2025 10:18AM |
$1.100 |
$2.630 |
risen by
139.09%
|
|
BCN - Price-sensitive ASX Announcement
Full Release
Key Points
- Beacon Minerals Limited identified near surface laterite mineralisation at the Iguana prospect.
- The mineralisation contains elevated nickel, cobalt, and scandium values.
- Aircore drilling confirmed broad zones of mineralisation, open in several directions.
- Further drilling and systematic sampling are planned to better define mineralisation.
- The project is part of the Jaurdi Gold Project in Western Australia.
- Beacon is expanding exploration efforts into battery metals.
- Existing infrastructure and project experience at Jaurdi will be leveraged for new exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hawsons Iron Ltd (HIO) ORDINARY FULLY PAID |
Materials |
$19 |
Update - Proposed issue of securities - HIO
|
16 Jul 2025 10:17AM |
$0.021 |
$0.015 |
fallen by
28.57%
|
|
| Ark Mines Limited (AHK) ORDINARY FULLY PAID |
Materials |
$22 |
Investor Presentation
|
16 Jul 2025 10:15AM |
$0.150 |
$0.310 |
risen by
106.67%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$111 |
Investor Briefing Presentation
|
16 Jul 2025 10:15AM |
$0.029 |
$0.120 |
risen by
313.79%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$111 |
Investor Briefing Invitation
|
16 Jul 2025 10:13AM |
$0.029 |
$0.120 |
risen by
313.79%
|
|
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$111 |
Reinstatement to Quotation
|
16 Jul 2025 10:11AM |
$0.029 |
$0.120 |
risen by
313.79%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited (ASX: LDX) will be reinstated to official quotation on the ASX.
- Reinstatement follows the company meeting ASX Listing Rule requirements.
- Details provided on capital raisings and changes to the board structure.
- Background given on the previous suspension of LDX shares.
- Steps outlined that LDX took to address issues leading to suspension.
- Reinstatement process and implications for shareholders are explained.
- Company has improved its financial position and governance structure.
- ASX confirms all necessary documentation and compliance are satisfied.
- Trading in LDX securities will recommence on 13 June 2024.
- Shareholders are advised of the process and next steps following reinstatement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lumos Diagnostics Holdings Limited (LDX) ORDINARY FULLY PAID |
Health Care |
$111 |
Lumos Signs Pivotal US FebriDx Agreement
|
16 Jul 2025 10:11AM |
$0.029 |
$0.120 |
risen by
313.79%
|
|
LDX - Price-sensitive ASX Announcement
Full Release
Key Points
- Lumos Diagnostics Holdings Limited has signed a pivotal US clinical trial agreement for FebriDx.
- The agreement is aimed at obtaining FDA clearance for FebriDx in the United States.
- FebriDx is a point-of-care diagnostic test that distinguishes between bacterial and viral infections.
- The agreement marks a significant step in Lumos Diagnostics’ US market strategy.
- The clinical trial is essential for the commercial launch of FebriDx in the US healthcare sector.
- The document discusses the clinical, regulatory, and commercial significance of the agreement.
- Details include projected timelines and the scope of the pivotal clinical study for FDA approval.
- The agreement may positively impact Lumos Diagnostics’ competitive position and financial prospects.
- Risks and contingencies related to FDA approval and market adoption are addressed.
- The agreement is a major advancement towards expanding Lumos Diagnostics' presence in the US diagnostics market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Zeus Resources Limited (ZEU) ORDINARY FULLY PAID |
Energy |
$6 |
Zeus Appoints US Business Development & Strategy Advisor
|
16 Jul 2025 10:08AM |
$0.017 |
$0.009 |
fallen by
47.06%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$37 |
Initial Director's Interest Notice - D Pfeffer
|
16 Jul 2025 10:05AM |
$0.210 |
$0.415 |
risen by
97.62%
|
|
| Monash IVF Group Limited (MVF) ORDINARY FULLY PAID |
Health Care |
$279 |
Appointment of Interim Chief Financial Officer
|
16 Jul 2025 10:04AM |
$0.730 |
$0.715 |
fallen by
2.05%
|
|
| Anson Resources Limited (ASN) ORDINARY FULLY PAID |
Materials |
$104 |
Anson Successfully Polishes Green River Lithium Chloride
|
16 Jul 2025 10:03AM |
$0.092 |
$0.064 |
fallen by
30.43%
|
|
ASN - Price-sensitive ASX Announcement
Full Release
Key Points
- Anson Resources successfully produced high-purity lithium chloride from Green River brine.
- The lithium chloride concentrate meets battery-grade requirements after proprietary polishing.
- The project is located in Utah, USA, targeting the US battery and EV markets.
- Production is an important step toward commercial battery-grade lithium output.
- The high-purity lithium chloride will be further processed into lithium carbonate and hydroxide.
- Ongoing project activities include permitting, site works, and preparing for commercial operations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clean Seas Seafood Limited (CSS) ORDINARY FULLY PAID |
Consumer Staple |
- |
Court Approves Scheme of Arrangement
|
16 Jul 2025 10:02AM |
$0.135 |
$0.135 |
fallen by
0%
|
|
| Clean TeQ Water Limited (CNQ) ORDINARY FULLY PAID |
Industrials |
$37 |
Appointment of New Director
|
16 Jul 2025 10:01AM |
$0.210 |
$0.415 |
risen by
97.62%
|
|
| Lord Resources Limited (LRD) ORDINARY FULLY PAID |
Materials |
$4 |
Notification regarding unquoted securities - LRD
|
16 Jul 2025 10:01AM |
$0.023 |
$0.020 |
fallen by
13.04%
|
|
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$26 |
Completion of Tranche 2 Placement and Cleansing Statement
|
16 Jul 2025 10:00AM |
$0.051 |
$0.105 |
risen by
105.88%
|
|
| Caspin Resources Limited (CPN) ORDINARY FULLY PAID |
Materials |
$26 |
Notification regarding unquoted securities - CPN
|
16 Jul 2025 10:00AM |
$0.051 |
$0.105 |
risen by
105.88%
|
|
| Scalare Partners Holdings Limited (SCP) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Appointment of Joint Company Secretary
|
16 Jul 2025 9:59AM |
$0.170 |
$0.072 |
fallen by
57.65%
|
|
| Terra Critical Minerals Limited (T92) ORDINARY FULLY PAID |
Energy |
$10 |
Terra Uranium Appoints Experienced Technical Advisors
|
16 Jul 2025 9:55AM |
$0.037 |
$0.067 |
risen by
81.08%
|
|
| Arena REIT (ARF) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$1,297 |
Update - Dividend/Distribution - ARF
|
16 Jul 2025 9:55AM |
$3.640 |
$3.190 |
fallen by
12.36%
|
|
Call 1300 880 160
Start a chat
Schedule a call
